LipidIQ

“AI-powered lipid analysis and personalized recommendations require an active subscription. All guideline-based calculators, risk scores, and reference content are available free of charge.” LipidIQ puts the complete 2026 Dyslipidemia Algorithm in your coat pocket — designed for cardiologists, internists, lipidologists, and any clinician managing cardiovascular risk. PREVENT CALCULATOR Compute 10-year and 30-year ASCVD risk using the validated 2026 AHA/ACC PREVENT equations. Includes PCE crosswalk so you can compare legacy risk estimates side-by-side. PRIMARY PREVENTION Risk-stratify patients into low, borderline, intermediate, and high-risk tiers. Get immediate statin intensity recommendations with class-of-recommendation and level-of-evidence badges — straight from the 2026 guidelines. SECONDARY PREVENTION Identify Very High-Risk ASCVD with the major event + high-risk condition checklist. Instantly see LDL-C and non-HDL-C goals, assess whether the patient is at goal, and receive stepwise add-on therapy guidance (statin → ezetimibe → PCSK9 inhibitor → bempedoic acid → inclisiran). LLT REFERENCE Quick-reference table of lipid-lowering therapies: statin intensities, ezetimibe, PCSK9 inhibitors, bempedoic acid, inclisiran, and icosapentaenoic acid — with expected LDL-C reductions and key notes. SPECIAL POPULATIONS Tailored guidance for diabetes, CKD, heart failure, statin intolerance, hypertriglyceridemia, pregnancy, and elderly patients (≥75 years). FH DIAGNOSTIC (DLCN SCORE) Dutch Lipid Clinic Network scoring tool for Familial Hypercholesterolemia — family history, clinical history, physical exam, LDL-C level, and genetic testing sections. Automatically classifies FH probability (Possible / Probable / Definite) with corresponding 2026 management recommendations. LDL CALCULATOR Martin-Hopkins equation to estimate LDL-C from a standard lipid panel, including a 180-cell Friedewald adjustment factor — useful when direct LDL-C is not available. REFERENCES 15 landmark citations (FOURIER, ODYSSEY OUTCOMES, IMPROVE-IT, REDUCE-IT, SHARP, CLEAR, JUPITER, and more) with direct DOI and PubMed links. Filter by topic: PCSK9i, Ezetimibe, Bempedoic Acid, FH, CKD, Statins, Inclisiran. DESIGNED FOR CLINICIANS • Dark and light themes with a single tap • No login, no data collection, fully offline-capable • Prominent clinical reference disclaimer on every screen • Clean, high-contrast UI optimised for quick bedside use CLINICAL REFERENCE ONLY. LipidIQ supports but does not replace clinical judgement. Always verify recommendations against current literature and individualise care.